These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 22100244

  • 1. Virus-like particles: potential veterinary vaccine immunogens.
    Liu F, Ge S, Li L, Wu X, Liu Z, Wang Z.
    Res Vet Sci; 2012 Oct; 93(2):553-9. PubMed ID: 22100244
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Current status and future directions of fish vaccines employing virus-like particles.
    Jeong KH, Kim HJ, Kim HJ.
    Fish Shellfish Immunol; 2020 May; 100():49-57. PubMed ID: 32130976
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetically engineered structure-based vaccine for bluetongue disease.
    Roy P.
    Vet Ital; 2004 May; 40(4):594-600. PubMed ID: 20422594
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Production of viral vaccines for veterinary use.
    van Gelder P, Makoschey B.
    Berl Munch Tierarztl Wochenschr; 2012 May; 125(3-4):103-9. PubMed ID: 22515027
    [Abstract] [Full Text] [Related]

  • 11. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.
    Vaccine; 2007 May 10; 25(19):3871-8. PubMed ID: 17337102
    [Abstract] [Full Text] [Related]

  • 12. Virus like particle-based vaccines against emerging infectious disease viruses.
    Liu J, Dai S, Wang M, Hu Z, Wang H, Deng F.
    Virol Sin; 2016 Aug 10; 31(4):279-87. PubMed ID: 27405928
    [Abstract] [Full Text] [Related]

  • 13. Virus-like particle-based vaccines against hepatitis C virus infection.
    Bellier B, Klatzmann D.
    Expert Rev Vaccines; 2013 Feb 10; 12(2):143-54. PubMed ID: 23414406
    [Abstract] [Full Text] [Related]

  • 14. Epitope engineering and molecular metrics of immunogenicity: a computational approach to VLP-based vaccine design.
    Joshi H, Lewis K, Singharoy A, Ortoleva PJ.
    Vaccine; 2013 Oct 01; 31(42):4841-7. PubMed ID: 23933338
    [Abstract] [Full Text] [Related]

  • 15. Virus-like Particle Vaccines and Platforms for Vaccine Development.
    Kheirvari M, Liu H, Tumban E.
    Viruses; 2023 May 02; 15(5):. PubMed ID: 37243195
    [Abstract] [Full Text] [Related]

  • 16. Major findings and recent advances in virus-like particle (VLP)-based vaccines.
    Mohsen MO, Zha L, Cabral-Miranda G, Bachmann MF.
    Semin Immunol; 2017 Dec 02; 34():123-132. PubMed ID: 28887001
    [Abstract] [Full Text] [Related]

  • 17. Enveloped virus-like particle platforms: vaccines of the future?
    Pitoiset F, Vazquez T, Bellier B.
    Expert Rev Vaccines; 2015 Jul 02; 14(7):913-5. PubMed ID: 25968245
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Live virus vaccines for use in animals.
    Bostock CJ.
    Dev Biol Stand; 1995 Jul 02; 84():41-8. PubMed ID: 7796966
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.